New biologic offers hope for MS patients
According to the National Multiple Sclerosis Society, an estimated 10,000 new cases of multiple sclerosis are diagnosed every year. The most common form of MS at the time of diagnosis is the relapsing-remitting form, in which acute signs and symptoms occur intermittently and will go into intermission either spontaneously or with steroid therapy.
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Related Content
